Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Plos One|December 19, 2014
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CSEoghan de Barra, Susanne H Hodgson, Katie J Ewer, et al.
Plos Pathogens|April 28, 2026
Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10Rosie M Mundy, Kasim Waraich, Emily A Bates, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in miceCarly M Bliss, Alec W Freyn, Tom G Caniels, et al.
Ebiomedicine|May 28, 2024
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoproteinCarly M Bliss, Raffael Nachbagauer, Chiara Mariottini, et al.
Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2020
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in MiceAlec W Freyn, Jamile Ramos da Silva, Victoria C Rosado, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Plos One|September 26, 2014
Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposureSumi Biswas, Prateek Choudhary, Sean C Elias, et al.
Scientific Reports|February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAPCarly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
Pageof 3